Processa shareholders approve 200,000-share increase to 2019 Omnibus Incentive Plan at annual meeting

Processa Pharmaceuticals, Inc.

All six director nominees elected with votes for ranging from 696,796 to 710,505; broker non-votes 825,288.
Amendment to 2019 Omnibus Incentive Plan to increase shares by 200,000 approved: 579,877 for, 152,958 against, 2,700 abstain.
Ratification of Cherry Bekaert as auditor: 1,541,664 for, 12,770 against, 6,389 abstain.
Advisory say-on-pay approved: 640,726 for, 89,886 against, 4,923 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.